Journal of Immunology Research / 2016 / Article / Tab 1

Research Article

Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren’s Syndrome

Table 1

Clinical and laboratory characteristics of primary Sjogren’s syndrome and sicca patients.

FeaturesSjogren’s syndrome ()Sicca () value

Age at diagnosis, years56.7 ± 1.3258.0 ± 2.660.651
Sex, female (%)68 (98.6)21 (95.5)0.427
BMI (kg/m2)21.9 ± 0.3422.5 ± 0.630.356
Disease duration, years8.7 ± 0.785.7 ± 1.09
Anti-Ro (SSA), (%)63 (91.3)0 (0.0)<
Anti-La (SSB), (%)43 (62.3)0 (0.0)<
Antinuclear antibody, (%)60 (87.0)3 (13.6)<
Rheumatoid factor, (%)37/64 (57.8)7 (31.8)
ESR (mm/hr)26.6 ± 2.5011.5 ± 1.64<
CRP (mg/dL)0.24 ± 0.060.13 ± 0.100.365
25(OH)-D3 (ng/mL)22.0 ± 1.3228.0 ± 2.69
BAFF (pg/mL)1543 ± 1411200 ± 1820.225
β2 microglobulin (mg/L)1.57 ± 0.081.19 ± 0.08
Extraglandular involvement (%)35 (50.7)0
ESSDAI1.5 ± 0.170

Data are presented as mean ± SEM for continuous data and number (percentage) for categorical variables. BMI = body mass index; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein; BAFF = B cell activation of the TNF family; ESSDAI = EULAR Sjogren’s syndrome disease activity index; .

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.